Advertisement
New Zealand markets close in 2 hours 49 minutes
  • NZX 50

    12,769.08
    -51.20 (-0.40%)
     
  • NZD/USD

    0.6183
    -0.0001 (-0.01%)
     
  • NZD/EUR

    0.5575
    -0.0005 (-0.10%)
     
  • ALL ORDS

    8,321.90
    +28.80 (+0.35%)
     
  • ASX 200

    8,099.70
    +24.00 (+0.30%)
     
  • OIL

    69.31
    +0.34 (+0.49%)
     
  • GOLD

    2,589.80
    +9.20 (+0.36%)
     
  • NASDAQ

    19,423.07
    +185.76 (+0.97%)
     
  • FTSE

    8,240.97
    +47.03 (+0.57%)
     
  • Dow Jones

    41,096.77
    +235.06 (+0.58%)
     
  • DAX

    18,518.39
    +188.12 (+1.03%)
     
  • Hang Seng

    17,494.07
    +253.68 (+1.47%)
     
  • NIKKEI 225

    36,671.60
    -161.67 (-0.44%)
     
  • NZD/JPY

    87.2490
    -0.4190 (-0.48%)
     

B&G Foods (BGS) Q2 Earnings Meet Estimates, Unit Volumes Dip

B&G Foods, Inc. BGS posted second-quarter 2024 results, wherein both net sales and earnings experienced year-over-year declines. While the bottom line matched the Zacks Consensus Estimate, the top line surpassed the same. Management pulled down its guidance for 2024.

B&G Foods is steadfast in its pursuit of enhancing organic growth and refining its portfolio, even amid short-term challenges in the demand for consumer-packaged foods. The second-quarter results met expectations, with the base business net sales showing a sequential increase from the first quarter.

Additionally, the company recently refinanced a significant portion of its long-term debt, extending maturity dates by several years to lower balance sheet risk. Additionally, B&G Foods is actively exploring potential divestitures to curtail debt, sharpen its focus on core businesses and pave the way for long-term growth.

B&G Foods, Inc. Price, Consensus and EPS Surprise

B&G Foods, Inc. price-consensus-eps-surprise-chart | B&G Foods, Inc. Quote

Quarterly Details

B&G Foods posted adjusted earnings of 8 cents per share, which came in line with the Zacks Consensus Estimate. Also, the bottom line declined 46.7% year over year.

Net sales of $444.6 million declined 5.3% year over year, mainly due to the divestiture of the Green Giant U.S. shelf-stable product line (divested on Nov 8, 2023), reduced unit volumes, lower net pricing and effects of product mix. However, net sales surpassed the Zacks Consensus Estimate of $435 million.

Base business net sales declined 2.5% to $444.6 million due to lower net pricing, an adverse product mix, reduced unit volumes and currency headwinds.

The adjusted gross profit of $93.2 million decreased from $102.7 million in the year-ago period. The adjusted gross margin contracted 90 basis points (bps) to 21%. 

SG&A expenses declined 9.9% to $43.1 million due to lower consumer marketing costs, reduced warehousing expenses and lower selling costs, partly offset by elevated general and administrative expenses. As a percentage of net sales, SG&A expenses fell 0.5 percentage points to 9.7%.

Adjusted EBITDA fell 6.6% to $63.9 million due to lower base business net sales and the impact of the Green Giant U.S. shelf-stable divestiture. The adjusted EBITDA margin contracted 20 bps to 14.4%.

Segment Details

Specialty: Net sales came in at $146.6 million, down 4.7% year over year. The decline was primarily due to the lower pricing of Crisco as well as lower overall volumes.

Meals: Net sales of $107.9 million dipped 5.5% year over year due to lower volumes, partly made up by elevated net pricing.

Frozen & Vegetables: Net sales came in at $91.6 million, down 15% year over year. The downtick was due to the divestiture of Green Giant U.S. shelf-stable products, a decrease in volume, increased spending on promotional trade activities and changes in product mix within the frozen category.

Spices & Flavor Solutions: Net sales came in at $98.5 million, up 4.9% year over year on improved volumes.

Other Updates & Guidance

B&G Foods ended the quarter with cash and cash equivalents of $40.3 million, net long-term debt of $1,779 million and total shareholders’ equity of nearly $765 million.

For fiscal 2024, management now anticipates net sales in the band of $1.945-$1.970 billion compared with the earlier view of $1.955-$1.985 billion. In fiscal 2023, net sales amounted to $2,062.3 million ($2.06 billion).

The company anticipates adjusted EBITDA in the range of around $300-$315 million now compared with $300-$320 million projected earlier. The company recorded an adjusted EBITDA of $318 million in fiscal 2023.

Adjusted earnings per share (EPS) for fiscal 2024 are envisioned to be between 70 and 90 cents, lower than the earlier guidance range of 75-95 cents. In fiscal 2023, the company posted an adjusted EPS of 99 cents.

Shares of this Zacks Rank #4 (Sell) company have tumbled 25% in the past three months compared with the industry’s decline of 3.9%

Better-Ranked Staple Bets

Vital Farms VITL offers a range of produced pasture-raised foods. It currently sports a Zacks Rank #1 (Strong Buy). VITL has a trailing four-quarter earnings surprise of 102.1%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate Vital Farms’ current financial-year sales and EPS indicate growth of 24.9% and 66.1%, respectively, from the year-ago reported numbers. 

Philip Morris PM, a tobacco company, has a trailing four-quarter earnings surprise of 1.8%, on average. PM currently carries a Zacks Rank #2 (Buy).

The Zacks Consensus Estimate for Philip Morris’ current financial-year sales and earnings indicates growth of 5.8% and almost 7%, respectively, from the prior-year reported levels.

Colgate-Palmolive CL, which manufactures and sells consumer products, currently carries a Zacks Rank #2. CL delivered an earnings surprise of 4.8% in the trailing four quarters, on average.

The Zacks Consensus Estimate for Colgate-Palmolive’s current fiscal-year sales and earnings suggests growth of 3.8% and nearly 10.5%, respectively, from the year-ago reported numbers.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Philip Morris International Inc. (PM) : Free Stock Analysis Report

Colgate-Palmolive Company (CL) : Free Stock Analysis Report

B&G Foods, Inc. (BGS) : Free Stock Analysis Report

Vital Farms, Inc. (VITL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research